HK19595A - Fluoxetine useful for the treatment of diabetes - Google Patents

Fluoxetine useful for the treatment of diabetes

Info

Publication number
HK19595A
HK19595A HK19595A HK19595A HK19595A HK 19595 A HK19595 A HK 19595A HK 19595 A HK19595 A HK 19595A HK 19595 A HK19595 A HK 19595A HK 19595 A HK19595 A HK 19595A
Authority
HK
Hong Kong
Prior art keywords
fluoxetine
diabetes
useful
treatment
mammals
Prior art date
Application number
HK19595A
Other languages
English (en)
Inventor
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK19595A publication Critical patent/HK19595A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
HK19595A 1987-05-04 1995-02-09 Fluoxetine useful for the treatment of diabetes HK19595A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4550987A 1987-05-04 1987-05-04

Publications (1)

Publication Number Publication Date
HK19595A true HK19595A (en) 1995-02-17

Family

ID=21938301

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19595A HK19595A (en) 1987-05-04 1995-02-09 Fluoxetine useful for the treatment of diabetes

Country Status (11)

Country Link
EP (1) EP0294028B1 (de)
JP (1) JP2721507B2 (de)
KR (1) KR880013555A (de)
AT (1) ATE93721T1 (de)
AU (1) AU596296B2 (de)
DE (1) DE3883606T2 (de)
DK (1) DK238588A (de)
ES (1) ES2058272T3 (de)
HK (1) HK19595A (de)
PH (1) PH23901A (de)
ZA (1) ZA883115B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA912277B (en) * 1990-03-29 1992-11-25 Lilly Co Eli The selective occupation of serotonin ic receptors
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
EP2316456B1 (de) 2003-04-29 2017-06-14 Orexigen Therapeutics, Inc. Zubereitungen enthaltend einen Opioidantagonisten und Bupropion zur Beeinflussung von Gewichtsverlust
EP1951212A2 (de) * 2005-11-22 2008-08-06 Orexigen Therapeutics, Inc. Zusammensetzungen und verfahren zur erhöhung der insulinsensitivität
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
TW201811315A (zh) 2006-11-09 2018-04-01 美商歐瑞根治療有限公司 層狀醫藥調配物
KR20090090316A (ko) 2006-11-09 2009-08-25 오렉시젠 세러퓨틱스 인크. 체중 감량 약물을 투여하기 위한 단위 용량 팩키지 및 투여 방법
CA2725930A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
ES2762113T3 (es) 2010-01-11 2020-05-22 Nalpropion Pharmaceuticals Inc Métodos de proporcionar terapia de pérdida de peso en pacientes con depresión mayor
EP4104824A1 (de) 2012-06-06 2022-12-21 Nalpropion Pharmaceuticals LLC Zusammensetzung zur verwendung in einem verfahren zur behandlung von übergewicht und fettleibigkeit bei patienten mit hohem kardiovaskulärem risiko
US20150174083A1 (en) 2012-07-31 2015-06-25 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Use of fluoxetine for increasing meat and milk production
WO2014021801A1 (en) 2012-07-31 2014-02-06 Sanovel Hayvan Sagligi Ürünleri Sanayi Ve Ticaret A.S. Use of fluoxetine in animals
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4590213A (en) * 1983-04-08 1986-05-20 Eli Lilly And Company Anti-anxiety method
CA1267092A (en) * 1985-02-25 1990-03-27 Martin D. Hynes Analgesic composition containing codeine

Also Published As

Publication number Publication date
ATE93721T1 (de) 1993-09-15
EP0294028A3 (en) 1990-05-02
PH23901A (en) 1989-12-18
KR880013555A (ko) 1988-12-21
JPS63284126A (ja) 1988-11-21
ES2058272T3 (es) 1994-11-01
AU1553388A (en) 1988-11-10
AU596296B2 (en) 1990-04-26
EP0294028B1 (de) 1993-09-01
DK238588A (da) 1988-11-05
DK238588D0 (da) 1988-05-03
ZA883115B (en) 1990-01-31
JP2721507B2 (ja) 1998-03-04
DE3883606T2 (de) 1994-01-20
DE3883606D1 (de) 1993-10-07
EP0294028A2 (de) 1988-12-07

Similar Documents

Publication Publication Date Title
AU581269B2 (en) Difluoronucleosides
EP0471421A3 (en) Stabilizing power source apparatus
JPS5791915A (en) Novel lipid composition useful for dietetics, resuscitation and treatment
GB2081695B (en) Surface treatment for carbon
HK19595A (en) Fluoxetine useful for the treatment of diabetes
EP0311061A3 (en) Composition for the surface treatment of rubber
NO881270D0 (no) Framgangsmaate for aa redusere carboninnholdet i halvledere.
IE882529L (en) Platinum Coordination Compound
GB2211845B (en) Process for dechlorinating 4,5-dichlorofluoro-dioxolanes to obtain fluorodioxoles
AU2351688A (en) Vulcanizable fluororubber composition
IL85189A0 (en) Alkylmelatonins
GR79753B (de)
GB2198451B (en) Briquette treatment process
EP0238765A3 (en) 2,2-diphenoxy-n,n-dimethylaminoethane for improving cerebral oxygenation
GB2206821B (en) Improvements relating to surface treatment
GB8708576D0 (en) Distillation process
CS535588A1 (en) Device for lignocellulosic material continuous treatment
ZA884770B (en) Process for the oxidation of coal
GB8702771D0 (en) Treatment for burn
YU149786A (en) Process for alkylizing izoparaffin with olephinic agents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)